Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion

Business

A Johnson & Johnson building is shown in Irvine, California.

Mike Blake | Reuters

Johnson & Johnson announced Wednesday that it will develop and deliver 100 million doses of its coronavirus vaccine for the U.S. in a deal totaling more than $1 billion. 

The deal gives the U.S. the option to order an additional 200 million doses, the company said. 

“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, chief science officer at Johnson & Johnson, in a statement. 

This is developing news. Please check back later for updates. 

Products You May Like

Articles You May Like

Honor 300 Design, Colour Options Revealed; Tipster Leaks Key Specifications Ahead of Launch
‘Bachelor in Paradise’s Blake Horstmann Engaged to ‘Love Is Blind’s Giannina Gibelli
Shopping Todd Snyder’s Early Black Friday Deals
Shop Celebrity Beauty and Makeup Picks
Tame Impala’s Kevin Parker just announced a retro-futuristic musical instrument called Orchid